Benjamin L. Oakes is the Founder and CEO of Scribe Therapeutics, a company rewriting the story of disease and engineering the future of genetic medicine. Completing his PhD at University of California, Berkeley in 2017 - Oakes worked under the supervision of Jennifer A. Doudna, a 2020 Nobel prize winner. In this podcast, we explore Oakes' career path & and the practical application of his research to make huge advancements in the field.
Podden och tillhörande omslagsbild på den här sidan tillhör Scientistt. Innehållet i podden är skapat av Scientistt och inte av, eller tillsammans med, Poddtoppen.
